Determination of adefovir by LC-ESI-MS-MS and its application to a pharmacokinetic study in healthy chinese volunteers

Journal of Chromatographic Science

Volumn 47, Issue 10, 2009, Pages 889-894

  Zou, Jianjun ^a   Di, Bin ^b   Zhang, Junren ^c   Dai, Li ^b   Ding, Li ^b   Zhu, Yubing ^a   Fan, Hongwei ^a   Xiao, DaWei ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450158717     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/47.10.889     Document Type: Article

References (14)

1. E.R. Schiff, C. Lai, S. Hadziyannis, et al. Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre-and post-liver transplantation patients. Hepatology 38: 1419-1427 (2003).
2. S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote, et al. Adefovir dipivoxil for the treatment of hepatitis Be antigen-negative chronic hepatitis B. N. Engl. J. Med 348: 800-807 (2003).
3. M.G. Peters, H.H. Hann, P. Martin, et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology, 126: 91-101 (2004).
4. R.V. Srinivas, B.L. Robbins, M.C. Connelly, et al, Metabolismand in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 37: 2247-2250 (1993).
5. R.W. Sparidans, A. Veldkamp, R.M. Hoetelmans, et al, Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde. Chromatogr. B Biomed. Sci. Appl. 736: 115 (1999).
6. Z.Y. Meng, G.F. Dou, and W.Z. Sun. Pharmacokinetics of adefovir dipivoxil in monkeys and its distribution in rat tissues. Chin. J. Pharmacol. Toxicol. 17: 447-450 (2003)
7. L.Y. Zhao, X.Y. Chen, Y. Zhang. et al, Determination of adefovir in monkey plasma by liquid chromatography-tandem mass spectrometry. Acta. Pharmaceutica. Sinica. 38: 120 (2003).
8. H.C. Bi, G.P. Zhong, S. Zhou, et al. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study. Rapid Commun. Mass Spectrom., 19: 2911-2917 (2005).
9. Y. Liu, G. Xu, C. Xu, et al. Ultra sensitive method for the determination of 9-(2-phosphonylmethoxyethyl) adenine in human serum by liquid chromatography-tandem mass spectrometry. J.Chromatogr.B Analyt. Technol. Biomed. Life Sci., 803: 293 (2004).
10. X.Y. Chen, D. Liu, L. Zhu, et al. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of adefovir in human plasma. Rapid Commun. Mass Spectrom. 19: 1893-1898 (2005).
11. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.
12. R.V.S. Nirogi, V.N. Kandikere, andK. Mudigonda, et al. Quantitative Determination of Galantamine in Human Plasma by Sensitive Liquid Chromatography-Tandem Mass Spectrometry Using Loratadine as an Internal Standard. J. Chromatogr. Sci. 45: 97-103 (2007).
13. Y. Tian, Z.J. Zhang, J.B. Liang, et al. High-performance liquid chromatography-electrosprayIonization-mass spectrometric Determination of Emedastine Difumarate in Human Plasma and Its Pharmacokinetics. J. Chromatogr. Sci. 45: 158-164 (2007).
14. J.J. Zou, X.J. Bian, L. Ding, et al.Determination of Tegaserod by LCESI/MS/MS and its Application to a Pharmacokinetic Study in Healthy Chinese Volunteers. J.Chromatogr.B 861: 151-157 (2008).